Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-05-13

Clinical Trial Update: Vitamin C and Atrial Fibrillation After Cardiac Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating vitamin C for preventing atrial fibrillation after cardiac surgery was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin C (ascorbic acid)

Snippet

Sponsor: Regional Hospital of Scranton | Conditions: Atrial Fibrillation | Phase 3 | Status: WITHDRAWN